Fujian Wanchen Biotechnology Group Co.,Ltd. (SHE:300972)
China · Delayed Price · Currency is CNY 193.49
+1.30 (0.68%)
At close: Sep 8, 2025
SHE:300972 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 764.15 | 293.52 | -82.93 | 47.74 | 23.45 | 96.13 | Upgrade |
Depreciation & Amortization | 271.59 | 264.15 | 182.32 | 64.48 | 61.32 | 59.61 | Upgrade |
Other Amortization | 20.41 | 17.01 | 9.78 | 1 | - | - | Upgrade |
Loss (Gain) From Sale of Assets | 1.73 | 8.34 | 3.26 | 1.66 | 0.49 | 0.1 | Upgrade |
Asset Writedown & Restructuring Costs | 21.39 | 11 | 4.04 | 0.31 | 0.1 | 0.05 | Upgrade |
Loss (Gain) From Sale of Investments | -0.59 | -0 | -0.06 | -1.72 | -1.8 | - | Upgrade |
Provision & Write-off of Bad Debts | 3.17 | 3.39 | 4.95 | 0.78 | 0.05 | 0.01 | Upgrade |
Other Operating Activities | 630.25 | 373.79 | -26.99 | -1.99 | 5.18 | 8.48 | Upgrade |
Change in Accounts Receivable | -509.36 | -817.08 | -338.41 | -53.22 | -7.39 | 0.33 | Upgrade |
Change in Inventory | -841.36 | -1,420 | -635.44 | -44.73 | -4.57 | -9.16 | Upgrade |
Change in Accounts Payable | 1,049 | 1,900 | 1,754 | 54.56 | 22 | 0.7 | Upgrade |
Change in Other Net Operating Assets | 183.87 | 219.37 | 147.97 | 1.48 | - | - | Upgrade |
Operating Cash Flow | 1,590 | 848.35 | 1,023 | 70.38 | 98.82 | 156.24 | Upgrade |
Operating Cash Flow Growth | 0.04% | -17.08% | 1353.60% | -28.78% | -36.75% | -11.87% | Upgrade |
Capital Expenditures | -100.93 | -116.65 | -218.91 | -316.34 | -41.57 | -56.1 | Upgrade |
Sale of Property, Plant & Equipment | 8.87 | 20.44 | 17.55 | 0.36 | 0.37 | 0.2 | Upgrade |
Cash Acquisitions | - | - | -5.4 | - | - | - | Upgrade |
Investment in Securities | - | - | 0.06 | 20 | -18.23 | - | Upgrade |
Other Investing Activities | 0.62 | 0 | - | 1.76 | - | - | Upgrade |
Investing Cash Flow | -91.45 | -96.21 | -206.69 | -294.22 | -59.43 | -55.9 | Upgrade |
Long-Term Debt Issued | - | 1,106 | 613.22 | 265.97 | 90.7 | 88 | Upgrade |
Long-Term Debt Repaid | - | -752.14 | -396.64 | -114.49 | -175.35 | -129.86 | Upgrade |
Net Debt Issued (Repaid) | 292.83 | 353.84 | 216.58 | 151.47 | -84.65 | -41.86 | Upgrade |
Issuance of Common Stock | 142.83 | 298.8 | 9.45 | - | 245.42 | - | Upgrade |
Common Dividends Paid | -232.66 | -29.96 | -15.15 | -39.22 | -5.23 | -49.01 | Upgrade |
Dividends Paid | -232.66 | -29.96 | -15.15 | -39.22 | -5.23 | -49.01 | Upgrade |
Other Financing Activities | -396.14 | -319.22 | 11.39 | 10.41 | -12.26 | -3.08 | Upgrade |
Financing Cash Flow | -193.13 | 303.46 | 222.26 | 122.66 | 143.28 | -93.95 | Upgrade |
Foreign Exchange Rate Adjustments | -0 | -0 | -0 | - | - | -0 | Upgrade |
Net Cash Flow | 1,306 | 1,056 | 1,039 | -101.17 | 182.67 | 6.39 | Upgrade |
Free Cash Flow | 1,489 | 731.69 | 804.17 | -245.96 | 57.25 | 100.14 | Upgrade |
Free Cash Flow Growth | 7.70% | -9.01% | - | - | -42.83% | -27.20% | Upgrade |
Free Cash Flow Margin | 3.38% | 2.26% | 8.65% | -44.78% | 13.17% | 22.25% | Upgrade |
Free Cash Flow Per Share | 7.58 | 3.91 | 5.23 | -1.58 | 0.41 | 0.88 | Upgrade |
Cash Income Tax Paid | 401.9 | 642.9 | 93.11 | 9.01 | 3.49 | 2.98 | Upgrade |
Levered Free Cash Flow | 1,438 | 748.19 | 912.09 | -256.14 | 40.51 | 34.82 | Upgrade |
Unlevered Free Cash Flow | 1,474 | 779.97 | 930.05 | -253.51 | 43.74 | 39.54 | Upgrade |
Change in Working Capital | -121.92 | -122.86 | 928.7 | -41.88 | 10.04 | -8.13 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.